• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange.半胱胺通过二硫键交换机制消耗胱氨酸病白细胞颗粒部分中的胱氨酸。
Biochem J. 1985 Jun 15;228(3):545-50. doi: 10.1042/bj2280545.
2
Cystine depletion by WR-1065 in cystinotic cells. Mechanism of action.WR-1065对胱氨酸病细胞中胱氨酸的消耗作用。作用机制。
Biochem Pharmacol. 1985 Jun 15;34(12):2179-85. doi: 10.1016/0006-2952(85)90415-0.
3
Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions.正常和胱氨酸病富含溶酶体的白细胞颗粒组分中胱氨酸反向转运的特征
Biochem J. 1983 Nov 15;216(2):393-400. doi: 10.1042/bj2160393.
4
Effects of cysteamine and other thiols on cystine egress from isolated lysosome-rich fractions of cystinotic and normal leucocytes.半胱胺及其他硫醇对胱氨酸从胱氨酸病患者和正常白细胞富含溶酶体的分离组分中流出的影响。
Clin Chim Acta. 1983 Jul 31;132(1):17-22. doi: 10.1016/0009-8981(83)90228-0.
5
Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.泛硫乙胺和胱胺通过半胱胺 - 半胱氨酸混合二硫化物的外排作用,从胱氨酸病成纤维细胞中消耗胱氨酸。
J Clin Invest. 1984 Aug;74(2):411-6. doi: 10.1172/JCI111436.
6
Impaired clearance of free cystine from lysosome-enriched granular fractions of I-cell-disease fibroblasts.I细胞病成纤维细胞富含溶酶体的颗粒组分中游离胱氨酸清除受损。
Biochem J. 1986 Jul 1;237(1):9-15. doi: 10.1042/bj2370009.
7
Depletion of cystine in cystinotic fibroblasts by homocysteine. Synergism of cysteamine with various reducing agents in depletion of cystine from cystinotic fibroblasts.同型半胱氨酸对胱氨酸病成纤维细胞中胱氨酸的消耗作用。半胱胺与各种还原剂在胱氨酸病成纤维细胞中消耗胱氨酸的协同作用。
Biochem Pharmacol. 1990 Aug 15;40(4):879-85. doi: 10.1016/0006-2952(90)90330-n.
8
Handling of L-[35S]cystine by cysteamine-pretreated cystinotic and normal fibroblasts.半胱胺预处理的胱氨酸病成纤维细胞和正常成纤维细胞对L-[35S]胱氨酸的处理
Arch Biochem Biophys. 1983 Feb 1;220(2):361-9. doi: 10.1016/0003-9861(83)90425-3.
9
Lysosomal cystine storage in cystinosis and mucolipidosis type II.胱氨酸病和II型粘脂贮积症中的溶酶体胱氨酸贮积
Pediatr Res. 1985 Nov;19(11):1170-4. doi: 10.1203/00006450-198511000-00011.
10
Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester.正常白细胞和胱氨酸病白细胞对胱氨酸二甲酯的胱氨酸积累及清除情况
Proc Natl Acad Sci U S A. 1982 Jul;79(14):4446-50. doi: 10.1073/pnas.79.14.4446.

引用本文的文献

1
JIP4 deficiency causes a lysosomal storage disease arising from impaired cystine efflux.JIP4缺乏会导致一种由胱氨酸外排受损引起的溶酶体贮积病。
bioRxiv. 2025 Jun 8:2025.06.06.657909. doi: 10.1101/2025.06.06.657909.
2
Long-term outcomes in nephropathic cystinosis: a review.肾性胱氨酸病的长期预后:综述
Pediatr Nephrol. 2025 May 14. doi: 10.1007/s00467-025-06790-6.
3
Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles.用于眼胱氨酸病的基于金纳米颗粒的诊疗隐形眼镜。
Biosensors (Basel). 2025 Jan 3;15(1):16. doi: 10.3390/bios15010016.
4
Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.胱胺治疗在生命的头 2 个月开始对婴儿胱氨酸病的肾小球和肾小管肾脏功能的有益影响。
Mol Genet Metab. 2022 Aug;136(4):282-288. doi: 10.1016/j.ymgme.2022.06.009. Epub 2022 Jul 1.
5
Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.胱胺治疗起始年龄、治疗依从性与婴儿型遗传性胱氨酸病肾小球肾功能的关系。
Mol Genet Metab. 2022 Aug;136(4):268-273. doi: 10.1016/j.ymgme.2022.06.010. Epub 2022 Jul 2.
6
Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting.溶酶体胱氨酸动员塑造 TORC1 和组织生长对禁食的反应。
Science. 2022 Feb 18;375(6582):eabc4203. doi: 10.1126/science.abc4203.
7
In Vitro and In Vivo Models to Study Nephropathic Cystinosis.研究肾性胱氨酸病的体外和体内模型。
Cells. 2021 Dec 21;11(1):6. doi: 10.3390/cells11010006.
8
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride.胱氨酸病患者接受 0.55%盐酸半胱氨酸治疗的长期随访。
Br J Ophthalmol. 2021 May;105(5):608-613. doi: 10.1136/bjophthalmol-2020-316450. Epub 2020 Jun 27.
9
Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis.比利时胱氨酸病患者使用复方半胱胺滴眼液治疗的眼科结局:回顾性分析
Ophthalmol Ther. 2019 Dec;8(4):623-633. doi: 10.1007/s40123-019-00216-x. Epub 2019 Sep 27.
10
The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis.氨基糖苷类抗生素遗传霉素可允许翻译通读 CTNS W138X 无义突变,该突变存在于胱氨酸贮积症患者的成纤维细胞中。
Pediatr Nephrol. 2019 May;34(5):873-881. doi: 10.1007/s00467-018-4094-0. Epub 2018 Nov 9.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.胱氨酸病患者分离出的白细胞溶酶体中胱氨酸转运存在缺陷。
Science. 1982 Sep 24;217(4566):1263-5. doi: 10.1126/science.7112129.
3
Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes.胱氨酸病白细胞中富含溶酶体的分离组分的胱氨酸外排缺陷。
J Biol Chem. 1982 Aug 25;257(16):9570-5.
4
Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes.从分离出的正常和胱氨酸病患者的人白细胞溶酶体中氨基酸流出的模式。
J Biol Chem. 1982 Jun 10;257(11):6041-9.
5
Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions.正常和胱氨酸病富含溶酶体的白细胞颗粒组分中胱氨酸反向转运的特征
Biochem J. 1983 Nov 15;216(2):393-400. doi: 10.1042/bj2160393.
6
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.由于单个位点的半胱氨酸-精氨酸互换导致人E载脂蛋白的脂蛋白受体结合活性异常。
J Biol Chem. 1982 Mar 10;257(5):2518-21.
7
The metabolism of amino acids, peptides, and disulfides in lysosomes of fibroblasts cultured from normal individuals and those with cystinosis.正常个体及患胱氨酸病个体所培养的成纤维细胞溶酶体中氨基酸、肽和二硫化物的代谢
J Exp Med. 1970 Dec 1;132(6):1090-104. doi: 10.1084/jem.132.6.1090.
8
Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid.抗坏血酸降低培养的胱氨酸病成纤维细胞的游离胱氨酸含量。
Science. 1974 Dec 13;186(4168):1040-2. doi: 10.1126/science.186.4168.1040.
9
Use of dithiothreitol to correct cystine storage in cultured cystinotic fibroblasts.使用二硫苏糖醇纠正培养的胱氨酸病成纤维细胞中的胱氨酸储存。
Lancet. 1970 Apr 18;1(7651):811-2. doi: 10.1016/s0140-6736(70)92411-6.
10
Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.胱氨酸病。体外和体内通过氨基硫醇使细胞内胱氨酸耗竭。
J Clin Invest. 1976 Jul;58(1):180-9. doi: 10.1172/JCI108448.

半胱胺通过二硫键交换机制消耗胱氨酸病白细胞颗粒部分中的胱氨酸。

Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange.

作者信息

Gahl W A, Tietze F, Butler J D, Schulman J D

出版信息

Biochem J. 1985 Jun 15;228(3):545-50. doi: 10.1042/bj2280545.

DOI:10.1042/bj2280545
PMID:4026796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1145021/
Abstract

Cystinotic lysosome-rich leucocyte granular fractions, loaded with [35S]cystine, were exposed to different cystine-depleting agents. During a 30 min incubation at 37 degrees C, untreated cystinotic granular fractions lost negligible [35S]cystine when corrected for lysosome rupture. Granular fractions exposed to 0.1 mM-cysteamine lost 64% of their initial cystine, and hexosaminidase activity was decreased by 10%. This was accompanied by the formation of high concentrations of [35S]cysteine-cysteamine mixed disulphide within the granular-fraction pellet, and, in the presence of N-ethylmaleimide, increasing amounts of [35S]cysteine-N-ethylmaleimide adduct outside the granular fraction. In separate experiments, [35S]cystine exited cystinotic leucocyte lysosomes at a negligible rate (half-times 199 and 293 min), but [35S]cysteine-cysteamine mixed disulphide exhibited substantial egress (half-times 66 and 88 min) and was recovered intact outside the granular-fraction pellet. We conclude that cysteamine depletes lysosomes of cystine by participating in a thiol-disulphide interchange reaction to produce cysteine and cysteine-cysteamine mixed disulphide, both of which traverse the cystinotic leucocyte lysosomal membrane.

摘要

将富含溶酶体的胱氨酸病白细胞颗粒组分装载上[35S]胱氨酸后,使其接触不同的胱氨酸消耗剂。在37℃孵育30分钟期间,经校正溶酶体破裂后,未经处理的胱氨酸病颗粒组分损失的[35S]胱氨酸可忽略不计。暴露于0.1 mM半胱胺的颗粒组分损失了其初始胱氨酸的64%,并且己糖胺酶活性降低了10%。这伴随着在颗粒组分沉淀中形成高浓度的[35S]半胱氨酸 - 半胱胺混合二硫化物,并且在存在N - 乙基马来酰亚胺的情况下,颗粒组分外部的[35S]半胱氨酸 - N - 乙基马来酰亚胺加合物的量增加。在单独的实验中,[35S]胱氨酸以可忽略不计的速率(半衰期分别为199和293分钟)从胱氨酸病白细胞溶酶体中逸出,但[35S]半胱氨酸 - 半胱胺混合二硫化物表现出大量逸出(半衰期分别为66和88分钟),并在颗粒组分沉淀外部完整回收。我们得出结论,半胱胺通过参与硫醇 - 二硫化物交换反应来消耗溶酶体中的胱氨酸,以产生半胱氨酸和半胱氨酸 - 半胱胺混合二硫化物,这两者都穿过胱氨酸病白细胞溶酶体膜。